Literature DB >> 2180344

Reversal of bupivacaine epidural anesthesia by intermittent epidural injections of crystalloid solutions.

M D Johnson1, G A Burger, P S Mushlin, G R Arthur, S Data.   

Abstract

This study was designed to determine whether epidural motor blockade could be reversed by postoperative injections of crystalloid solutions via the epidural catheter. Twenty-seven patients (ASA physical status I, nonlaboring) had epidural anesthesia with 0.75% bupivacaine for elective cesarean delivery. Postoperatively, patients were randomized to receive three 15-mL injections (over 30 min) of crystalloid solutions (normal saline or Ringer's lactate) or no treatment (control) via the epidural catheter. Degree of motor and sensory blockade was evaluated with an investigator blinded to treatment group. Rate of resolution of sensory blockade was not different among groups. However, time for resolution of motor blockade was more than twice as long in the control group than in either treatment group (control = 178 +/- 70 min vs Ringer's lactate = 84 +/- 44 min, normal saline = 70 +/- 38 min, P = 0.001). The data suggest that unwanted motor blockade due to epidural anesthesia can be reversed by epidural injections of crystalloid solutions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180344     DOI: 10.1213/00000539-199004000-00009

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  Reversing Effect of Insulin on Local Anesthetics-Induced Sciatic Nerve Block in Rats.

Authors:  Jong Min Kim; Seok Hwa Choi
Journal:  Biomed Res Int       Date:  2019-03-11       Impact factor: 3.411

2.  Advantages of the Combination of Conscious Sedation Epidural Anesthesia Under Fluoroscopy Guidance in Lumbar Spine Surgery.

Authors:  Seung Youn Kang; Osama Nezar Kashlan; Ravindra Singh; Rahul Rane; Nitin Maruti Adsul; Sung Chan Jung; Jihwan Yi; Hae Sun Cho; Hyeun Sung Kim; Il-Tae Jang; Seong-Hoon Oh
Journal:  J Pain Res       Date:  2020-01-21       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.